Andrea K. Mccollum

Array ( [id] => 8405544 [patent_doc_number] => 20120237605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-20 [patent_title] => 'Multifunctional Metal Nanoparticles Having A Polydopamine-Based Surface and Methods of Making and Using the Same' [patent_app_type] => utility [patent_app_number] => 13/420189 [patent_app_country] => US [patent_app_date] => 2012-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 16073 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13420189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465613 [patent_doc_number] => 20120270780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'METHOD AND COMPOSITION FOR MODULATING ERYTHROPOIESIS' [patent_app_type] => utility [patent_app_number] => 13/419405 [patent_app_country] => US [patent_app_date] => 2012-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8159 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13419405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9245063 [patent_doc_number] => 08609343 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'Detection of bladder cancer' [patent_app_type] => utility [patent_app_number] => 13/417642 [patent_app_country] => US [patent_app_date] => 2012-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 13442 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13417642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9413607 [patent_doc_number] => 08697644 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-15 [patent_title] => 'Stable formulations for parenteral injection of peptide drugs' [patent_app_type] => utility [patent_app_number] => 13/417073 [patent_app_country] => US [patent_app_date] => 2012-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19640 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13417073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10272713 [patent_doc_number] => 20150157710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-11 [patent_title] => 'DUAL OX40 AGONIST/IL-2 CANCER THERAPY METHODS' [patent_app_type] => utility [patent_app_number] => 14/381785 [patent_app_country] => US [patent_app_date] => 2012-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16843 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11548471 [patent_doc_number] => 09617304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-11 [patent_title] => 'Pharmaceutical composition containing an endocytic motif and protein transduction domains for preventing or treating cancer' [patent_app_type] => utility [patent_app_number] => 14/002600 [patent_app_country] => US [patent_app_date] => 2012-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 8840 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11657287 [patent_doc_number] => 09670277 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-06 [patent_title] => 'Compositions and methods for treating inflammatory conditions of the ocular surface' [patent_app_type] => utility [patent_app_number] => 14/001594 [patent_app_country] => US [patent_app_date] => 2012-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 21 [patent_no_of_words] => 18626 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14001594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11657287 [patent_doc_number] => 09670277 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-06 [patent_title] => 'Compositions and methods for treating inflammatory conditions of the ocular surface' [patent_app_type] => utility [patent_app_number] => 14/001594 [patent_app_country] => US [patent_app_date] => 2012-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 21 [patent_no_of_words] => 18626 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14001594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9197674 [patent_doc_number] => 20130336989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'METHODS OF IDENTIFYING A PATIENT POPULATION' [patent_app_type] => utility [patent_app_number] => 14/001202 [patent_app_country] => US [patent_app_date] => 2012-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15514 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14001202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9318397 [patent_doc_number] => 20140050735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'TREATMENT OF FISTULIZING CHROHN\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 13/985732 [patent_app_country] => US [patent_app_date] => 2012-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17575 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13985732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9996070 [patent_doc_number] => 09040669 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-26 [patent_title] => 'HLA-restricted, peptide-specific antigen binding proteins' [patent_app_type] => utility [patent_app_number] => 13/984646 [patent_app_country] => US [patent_app_date] => 2012-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 46 [patent_no_of_words] => 24025 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8337573 [patent_doc_number] => 20120204282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING OCCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/367216 [patent_app_country] => US [patent_app_date] => 2012-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18134 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13367216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254142 [patent_doc_number] => 08617552 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'IL-17 antibodies' [patent_app_type] => utility [patent_app_number] => 13/349689 [patent_app_country] => US [patent_app_date] => 2012-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19171 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13349689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9197653 [patent_doc_number] => 20130336968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'PHARMACEUTICAL FORMULATION COMPRISING A BIOPHARMACEUTICAL DRUG' [patent_app_type] => utility [patent_app_number] => 13/995556 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10423 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10887740 [patent_doc_number] => 08911732 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-16 [patent_title] => 'Anti-mesothelin antibodies and immunoconjugates' [patent_app_type] => utility [patent_app_number] => 13/330414 [patent_app_country] => US [patent_app_date] => 2011-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 36 [patent_no_of_words] => 34166 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13330414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10090248 [patent_doc_number] => 09127060 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'Anti-Notch1 antibodies' [patent_app_type] => utility [patent_app_number] => 13/994349 [patent_app_country] => US [patent_app_date] => 2011-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 30 [patent_no_of_words] => 38675 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10919309 [patent_doc_number] => 20140322329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'MULTIPURPOSE GEL FOR VAGINAL DRYNESS WITH DIRECT AND DELAYED EFFECT' [patent_app_type] => utility [patent_app_number] => 13/992037 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2681 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8054103 [patent_doc_number] => 20120076793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'AGENT FOR PROMOTING HEPATIC CELL REPLICATION AND AGENT FOR IMPROVING INSULIN RESISTANCE' [patent_app_type] => utility [patent_app_number] => 13/309100 [patent_app_country] => US [patent_app_date] => 2011-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13104 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076793.pdf [firstpage_image] =>[orig_patent_app_number] => 13309100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9511905 [patent_doc_number] => 20140148396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'COMPOUNDS FOR TREATING CARDIAC DAMAGE AFTER ISCHAEMIA/REPERFUSION' [patent_app_type] => utility [patent_app_number] => 14/110805 [patent_app_country] => US [patent_app_date] => 2011-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15550 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9042602 [patent_doc_number] => 20130245240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'Bio-Hybrid Material, Production Method Therefor, and Stent' [patent_app_type] => utility [patent_app_number] => 13/989279 [patent_app_country] => US [patent_app_date] => 2011-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6374 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989279 [rel_patent_id] =>[rel_patent_doc_number] =>)